Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intravenous Hydromorphone for the Treatment of Acute Pain
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Summary
To observe the efficacy and safety of hydromorphone in the treatment of acute chest pain, and to explore the potential advantages of hydromorphone for analgesia in patients with acute chest pain, so as to provide more theoretical basis for individualized analgesia and rapid recovery in patients with acute chest pain.
Official title: Intravenous Acetaminophen Versus Intravenous Hydromorphone for the Treatment of Acute Pain: A Single-Center, Prospective, Single-Arm Study
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-01-01
Completion Date
2027-12-31
Last Updated
2025-11-17
Healthy Volunteers
No
Conditions
Interventions
Hydromorphone
Hydromorphone 1mg was given intravenously and conventional treatment was performed at the same time.
Locations (1)
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China